InvestorsHub Logo
Followers 5
Posts 563
Boards Moderated 0
Alias Born 08/19/2020

Re: None

Thursday, 01/20/2022 2:59:50 PM

Thursday, January 20, 2022 2:59:50 PM

Post# of 2720
$OPGN Marketbeat: "The main competitors of OpGen include Laboratory Co. of America, Quest Diagnostics, Guardant Health, Natera, Invitae, CareDx, Veracyte, Fulgent Genetics, RadNet, and Burning Rock Biotech."

Is lab giant Quest Diagnostics $DGX (MC US$17.03 Billion) the dark horse here? Quest snapping up competitor OpGen, Inc and its subsidiaries, patents (IP), and substantial cash hoard (larger than OPGN MC) for the Quest equivalent of minor cash would be smart now that Quest has recently formed partnerships with Wal-Mart and Safeway in-store health clinics for laboratory testing and is the laboratory provider to UnitedHealthcare with its 46 million members. Quest gets OpGen for their on-site automated rapid detection (and early warning) of dangerous pathogens (replacing dated lab culture methods) and detection of antibiotic resistance to drugs typically prescribed by health providers.

https://www.marketbeat.com/stocks/NASDAQ/OPGN/competitors-and-alternatives/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPGN News